STOCK TITAN

American Century entities (NYSE: MCS) disclose 5.0% beneficial stake in The Marcus Corporation

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research report beneficial ownership of common stock of The Marcus Corporation. As of 06/30/2026, they collectively report beneficial ownership of 1,197,597 shares of common stock, representing 5.0% of the class. The reporting persons have sole voting power and sole dispositive power over 1,197,597 shares and no shared voting or dispositive power. Various advisory clients of American Century Investment Management, Inc. are entitled to receive dividends and sale proceeds for these shares, but no single client holds more than 5% of the class. American Century Investment Management, Inc. is a wholly owned subsidiary of American Century Companies, Inc., which is controlled by the Stowers Institute for Medical Research.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 1,197,597 shares Beneficial ownership of The Marcus Corporation common stock as reported
Percent of class 5.0% Percentage of The Marcus Corporation common stock class beneficially owned
Sole voting power 1,197,597 shares Shares over which reporting persons have sole power to vote
Shared voting power 0 shares Shares over which reporting persons have shared voting power
Sole dispositive power 1,197,597 shares Shares over which reporting persons have sole power to dispose
CUSIP 566330106 CUSIP number for The Marcus Corporation common stock
beneficial owner financial
"that is a beneficial owner of securities that are the subject of this schedule"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole voting power financial
"5 | Sole Voting Power 1,197,597.00 6 | Shared Voting Power 0.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"7 | Sole Dispositive Power 1,197,597.00 8 | Shared Dispositive Power 0.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"securities that are the subject of this schedule (the "Subject Securities")"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
investment adviser financial
"an investment adviser registered under Section 203 of the Investment Advisers Act of 1940"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.

FAQ

What percentage of The Marcus Corporation (MCS) is owned by the American Century entities?

The American Century entities report beneficial ownership of 5.0% of The Marcus Corporation’s common stock. This corresponds to 1,197,597 shares with sole voting and dispositive power reported as of 06/30/2026.

How many MCS shares do the American Century entities beneficially own?

They report beneficial ownership of 1,197,597 shares of The Marcus Corporation common stock. These shares are held with sole voting and sole dispositive power and represent 5.0% of the outstanding class.

Who are the reporting persons on this Schedule 13G for MCS?

The reporting persons are American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, all associated through a control relationship over the reported holdings of The Marcus Corporation common stock.

Do any individual American Century clients own more than 5% of MCS?

No individual client does. The filing states that no single client advised by American Century Investment Management, Inc. owns more than 5% of The Marcus Corporation’s common stock, even though all such accounts together total 5.0%.

What type of control do the American Century entities have over their MCS shares?

They report sole voting power and sole dispositive power over 1,197,597 shares of The Marcus Corporation common stock, with no shared voting or shared dispositive power indicated in the ownership breakdown.

What is the relationship among ACIM, ACC, and the Stowers Institute in this MCS filing?

American Century Investment Management, Inc. is a wholly owned subsidiary of American Century Companies, Inc., and American Century Companies, Inc. is controlled by the Stowers Institute for Medical Research, which is identified as the control entity for these beneficial holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





566330106

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



American Century Investment Management, Inc.
Signature:American Century Investment Management, Inc.
Name/Title:/s/ John Pak / Senior Vice President
Date:08/14/2026
American Century Companies, Inc.
Signature:American Century Companies, Inc.
Name/Title:/s/ John Pak / Senior Vice President
Date:08/14/2026
Stowers Institute for Medical Research
Signature:Stowers Institute for Medical Research
Name/Title:/s/ Joselyn Verschelden / Authorized Signer
Date:08/14/2026
Exhibit Information

EXHIBIT Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule. Dated this 14th day of August, 2026. AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM") AMERICAN CENTURY COMPANIES, INC. ("ACC") By: __/s/ John Pak___________________ John Pak Senior Vice President, ACIM and ACC STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC By: __/s/ Joselyn Verschelden_________ Joselyn Verschelden Authorized Signer